TALEN

TALEN3-yap1

ID

ZDB-TALEN-170522-2

Name

TALEN3-yap1

Previous Names

None

Target

yap1 (1)

Target Sequence 1

5' - CCGAACCAGCACAACC - 3'

Target Sequence 2

5' - CCCCGAACATGGACGA - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
ncv101	yap1
ncv117	yap1

Expression

Gene expression in Wild Types + TALEN3-yap1

No data available

Phenotype

Phenotype resulting from TALEN3-yap1

No data available

Phenotype of all Fish created by or utilizing TALEN3-yap1

Phenotype	Fish	Conditions	Figures
intersegmental vessel angiogenic sprout increased amount, abnormal	yap1^{ncv101/ncv101}; y1Tg	standard conditions	Fig. 7 from Nakajima et al., 2017
dorsal longitudinal anastomotic vessel morphology, abnormal	yap1^{ncv101/ncv101}; y1Tg	standard conditions	Fig. 7 from Nakajima et al., 2017
dorsal longitudinal anastomotic vessel constricted, abnormal	yap1^{ncv101/ncv101}; y1Tg	standard conditions	Fig. 7 from Nakajima et al., 2017
cerebellar central artery constricted, abnormal	yap1^{ncv101/ncv101}; y1Tg	standard conditions	Fig. 7 from Nakajima et al., 2017
lateral dorsal aorta angiogenic sprout increased amount, abnormal	yap1^{ncv101/ncv101}; y1Tg	standard conditions	Fig. 7 from Nakajima et al., 2017
heart rudiment hand2 expression increased distribution, abnormal	lats2^{ncv108/ncv108}; yap1^ncv117/+	control	Fig. 3 from Fukui et al., 2018
anterior lateral plate mesoderm Ab13-smad labeling decreased amount, abnormal	wwtr1^{ncv114/ncv114}; yap1^{ncv117/ncv117}	control	Fig. 6 from Fukui et al., 2018
posterior lateral plate mesoderm hand2 expression decreased amount, abnormal	wwtr1^{ncv114/ncv114}; yap1^{ncv117/ncv117}	control	Fig. 5 from Fukui et al., 2018
anterior lateral plate mesoderm bmp2b expression decreased amount, abnormal	wwtr1^{ncv114/ncv114}; yap1^{ncv117/ncv117}	control	Fig. 6 from Fukui et al., 2018
immature eye Ab13-smad labeling decreased amount, abnormal	wwtr1^{ncv114/ncv114}; yap1^{ncv117/ncv117}	control	Fig. 6 from Fukui et al., 2018
anterior lateral plate mesoderm hand2 expression decreased amount, abnormal	wwtr1^{ncv114/ncv114}; yap1^{ncv117/ncv117}	control	Fig. 5 from Fukui et al., 2018
dorsal longitudinal anastomotic vessel endothelial cell EGFP expression absent, abnormal	yap1^{ncv101/ncv101}; ncv1Tg; ncv36Tg; nkuasgfp1aTg	standard conditions	Fig. 2 from Nakajima et al., 2017
intersegmental vessel endothelial cell EGFP expression absent, abnormal	yap1^{ncv101/ncv101}; ncv1Tg; ncv36Tg; nkuasgfp1aTg	standard conditions	Fig. 2 from Nakajima et al., 2017
dorsal aorta endothelial cell EGFP expression absent, abnormal	yap1^{ncv101/ncv101}; ncv1Tg; ncv36Tg; nkuasgfp1aTg	standard conditions	Fig. 2 from Nakajima et al., 2017
posterior cardinal vein endothelial cell EGFP expression absent, abnormal	yap1^{ncv101/ncv101}; ncv1Tg; ncv36Tg; nkuasgfp1aTg	standard conditions	Fig. 2 from Nakajima et al., 2017
hindbrain endothelial cell EGFP expression absent, abnormal	yap1^{ncv101/ncv101}; ncv12Tg; ncv1Tg; nkuasgfp1aTg	standard conditions	Fig. 1 from Nakajima et al., 2017

Citations